Bladder cancer

About 700 patients participated in phase 3, randomized, double-blind trial named CheckMate 274; half were given nivolumab and the other half placebo after having surgery with chemotherapy beforehand. …

," said study lead author Vivek Nimgaonkar, a Perelman School of Medicine student and graduate associate with the Penn Center for Precision Medicine. "Our research has implications for patients, who start…

New York, US, April 26, 2022 (GLOBE NEWSWIRE) -- Bladder Cancer Detection Kit Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Bladder Cancer Detection Kit Market Information by…

," said Lubomir Hadjiyski, Ph.D., a professor of radiology at the University of Michigan Medical School and the senior author of the study. When patients develop bladder cancer, surgeons often remove the…

A total of 120 patients from 15 hospitals in the UK were recruited for the NEOBLADE phase two randomized control trial, led by Professor Syed A Hussain from the University of Sheffield's Department of Oncology and Metabolism. …

Since the 1940s, the main treatment for killing cancer cells has involved chemotherapy drugs, which kill the cells directly. But many of the current drugs kill their immune cells to invade cancer cells. In…

PHILADELPHIA, PA, Feb. 10, 2022 (GLOBE NEWSWIRE) -- The Cancer Support Community (CSC), the world’s largest provider of cancer support with a network of 175 locations across the United States and Canada, has recently expanded its…

Las Vegas, USA, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Non-Muscle Invasive Bladder Cancer Pipeline Insights | Clinical Trials Report 2022 by DelveInsight  Non-Muscle Invasive Bladder Cancer Pipeline involves 30+ key companies…

The pan-FGFR tyrosine kinase inhibitor erdafitinib (Balversa) was active and safe in patients with locally advanced or metastatic urothelial…

MELBOURNE, Australia and NANTES, France, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and Nantes-based ATONCO S.A.S. (‘ATONCO’) today announce that a first patient has been dosed in a…